Potassium, sodium, calcium and glutamate-gated channels: Pore architecture and ligand action

Journal of Neurochemistry

Volumn 88, Issue 4, 2004, Pages 782-799

  Zhorov, Boris S ^a   Tikhonov, Denis B ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Channel agonists; Glutamate gated ion channels; Ligand receptor interactions; Open channel block; Voltage gated ion channels

Indexed keywords

1 (1 ADAMANTYLMETHYLAMMONIO) 5 TRIMETHYLAMMONIOPENTANE DIBROMIDE; 1 ADAMANTYLMETHYLAMMONIO 5 AMMONIOPENTANE DIBROMIDE; 1' (6 CYANO 1,2,3,4 TETRAHYDRO 2 NAPHTHYL) 3,4 DIHYDRO 6 METHANESULFONAMIDOSPIRO[2H 1 BENZOPYRAN 2,4' PIPERIDIN] 4 OL; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMINOACRIDINE; BUPIVACAINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; CORREOLIDE; DILTIAZEM; DIZOCILPINE; GLUTAMIC ACID; IEM 1857; ION CHANNEL; LIDOCAINE ETHOBROMIDE; LIGAND; LOCAL ANESTHETIC AGENT; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N [(2,6 DIMETHYLPHENYL)CARBAMOYLMETHYL]TRIMETHYLAMMONIUM; NICARDIPINE; PANCURONIUM; PHENCYCLIDINE; PIPERANOMETOZINE; PIPERIDINE DERIVATIVE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROCAINE; SODIUM CHANNEL; SODIUM ION; UK 78 282; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

AMINO ACID SEQUENCE; ANIMAL; BACTERIUM; BINDING SITE; CELL MEMBRANE; CHANNEL GATING; CHEMICAL STRUCTURE; CHEMISTRY; GLUTAMATE GATED CHANNEL; HUMAN; METABOLISM; NONHUMAN; PHYSIOLOGY; POTASSIUM CHANNEL KCSA; POTASSIUM CHANNEL KVAP; POTASSIUM CHANNEL MTHK; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE ALIGNMENT; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 1042266533     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02261.x     Document Type: Review

References (181)

1. Almers W. and McCleskey E. W. (1984) Non-selective conductance in calcium channels of frog muscle: calcium selectivity in a single-file pore. J. Physiol. (Lond.) 353, 585-608.
2. Alpert L. A., Fozzard H. A., Hanck D. A. and Makielski J. C. (1989) Is there a second external lidocaine binding site on mammalian cardiac cells? Am. J. Physiol. 257, H79-H84.
3. Anis N. A., Berry S. C., Burton N. R. and Lodge D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 79, 565-575.
4. Antonov S. M. and Johnson J. W. (1996) Voltage-dependent interaction of open-channel blocking molecules with gating of NMDA receptors in rat cortical neurons. J. Physiol. (Lond.) 493, 425-445.
5. Arias H. R. (1998) Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim. Biophys. Acta. 1376, 173-220.
6. Armstrong C. M. (1969) Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons. J. General Physiol. 54, 553-575.
7. Armstrong C. M. (1971) Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J General Physiol. 58, 413-437.
8. Armstrong C. M. (1975) Potassium pores of nerve and muscle membranes. Membranes 3, 325-358.
9. Armstrong C. M. and Croop R. S. (1982) Simulation of Na channel inactivation by thiazine dyes. J. General Physiol. 80, 641-662.
10. Armstrong C. M. and Hille B. (1972) The inner quaternary ammonium ion receptor in potassium channels of the node of Ranvier. J. General Physiol. 59, 388-400.
11. Backx P. H., Yue D. T., Lawrence J. H., Marban E. and Tomaselli G. F. (1992) Molecular localization of an ion-binding site within the pore of mammalian sodium channels. Science 257, 248-251.
12. Bahring R., Bowie D., Benveniste M. and Mayer M. L. (1997) Permeation and block of rat GIuR6 glutamate receptor channels by internal and external polyamines. J Physiol. (Lond.) 502, 575-589.
13. Barnes S. and Hille B. (1988) Veratridine modifies open sodium channels. J. General Physiol. 91, 421-443.
14. Benveniste M. and Mayer M. L. (1995) Trapping of glutamate and glycine during open channel block of rat hippocampal neuron NMDA receptors by 9-aminoacridine. J. Physiol. (Lond.) 483, 367-384.
15. Bertolino M., Baraldi M., Parenti C., Braghiroli D., DiBella M., Vicini S. and Costa E. (1993) Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors Channels 1, 267-278.
16. Bolshakov K. V., Tikhonov D. B., Gmiro V. E. and Magazanik L. G. (2000) Different arrangement of hydrophobic and nucleophilic components of channel binding sites in N-methyl-D-aspartate and AMPA receptors of rat brain is revealed by channel blockade. Neurosci. Lett. 291, 101-104.
17. Bormann J. (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol. 166, 591-592.
18. Bowie D. and Mayer M. L. (1995) Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 15, 453-462.
19. Brackley P. T., Bell D. R., Choi S. K., Nakanishi K. and Usherwood P. N. (1993) Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins. J. Pharmacol. Exp. Ther. 266, 1573-1580.
20. Burnashev N., Villarroel A. and Sakmann B. (1996) Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R. site residues. J. Physiol. (Lond.) 496, 165-173.
21. Cahalan M. D. and Almers W. (1979) Block of sodium conductance and gating current in squid giant axons poisoned with quaternary strychnine. Biophys. J. 27, 57-73.
22. - channel and its structural implications. Biofactors 11, 63-64.
23. 2+ channels. Annu. Rev. Cell. Dev. Biol. 16, 521-555.
24. Catterall W. A. (2002) Molecular mechanisms of gating and drug block of sodium channels. Novartis Found. Symp 241, 206-218.
25. Chahine M., Sirois J., Marcotte P., Chen L. and Kallen R. G. (1998) Extrapore residues of the S5-S6 loop of domain 2 of the voltage-gated skeletal muscle sodium channel (rSkMI) contribute to the mu-conotoxin GIIIA binding site. Biophys. J. 75, 236-246.
26. Chen G. Q., Cui C., Mayer M. L. and Gouaux E. (1999) Functional characterization of a potassium-selective prokaryotic glutamate receptor. Nature 402, 817-821.
27. Choi K. L., Mossman C., Aube J. and Yellen G. (1993) The internal quaternary ammonium receptor site of Shaker potassium channels. Neuron 10, 533-541.
28. Choudhary G., Yotsu-Yamashita M., Shang L., Yasumoto T. and Dudley S. C. J. (2003) Interactions of the C-11 hydroxyl of tetrodotoxin with the sodium channel outer vestibule. Biophys. J. 84, 287-294.
29. Courtney K. R. (1975) Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J. Pharmacol. Exp. Ther. 195, 225-236.
30. + channels by TEA: results from molecular dynamics simulations of the KcsA channel. J. General Physiol. 118, 207-218.
31. + channel block by verapamil and related compounds in rat alveolar epithelial cells. J. General Physiol. 106, 745-779.
32. + channel behaves like an open-channel blocker. Neuron 7, 743-753.
33. Dingledine R., Borges K., Bowie D. and Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
34. 2+-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc. Natl Acad. Sci. USA 92, 9298-9302.
35. + conduction and selectivity. Science 280, 69-77.
36. + channel mutant: possible localization of a binding site at the outer vestibule. Biophys. J. 69, 1657-1665.
37. Egan T. M., Dagan D. and Levitan I. B. (1993) Properties and modulation of a calcium-activated potassium channel in rat olfactory bulb neurons. J. Neurophysiol. 69, 1433-1442.
38. Eldefrawi A. T., Eldefrawi M. E., Konno K., Mansour N. A., Nakanishi K., OltZ. E. and Usherwood P. N. (1988) Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. Proc. Natl Acad. Sci. USA 85, 4910-4913.
39. Eller P., Berjukov S., Wanner S., Huber I., Hering S., Knaus H. G., Toth G., Kimball S. D. and Striessnig J. (2000) High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br. J Pharmacol. 130, 669-677.
40. Ellinor P. T., Zhang J. F., Horne W. A. and Tsien R. W. (1994) Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin. Nature 372, 272-275.
41. 2+ interactions. Neuron 15, 1121-1132.
42. Ertel E. A., Campbell K. P., Harpold M. M. et al. (2000) Nomenclature of voltage-gated calcium channels. Neuron 25, 533-535.
43. + channels to intracellular spermine. FEBS Lett. 356, 199-203.
44. Felix J. P., King V. F., Shevell J. L., Garcia M. L., Kaczorowski G. J., Bick I. R. and Slaughter R. S. (1992) Bis (benzylisoquinoline) analogs of tetrandrine block 1-type calcium channels: evidence for interaction at the diltiazem-binding site. Biochemistry 31, 11793-11800.
45. Felix J. P., Bugianesi R. M., Schmalhofer W. A. et al. (1999) Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3. Biochemistry 38, 4922-4930.
46. Feng Z. P., Hamid J., Doering C., Bosey G. M., Snutch T. P. and Zamponi G. W. (2001) Residue Gly1326 of the N-type calcium channel alpha 1B subunit controls reversibility of omega-conotoxin GVIA and MVIIA block. J. Biol. Chem. 276, 15728-15735.
47. Ferrer-Montiel A. V., Merino J. M., Planells-Cases R., Sun W. and Montal M. (1998) Structural determinants of the blocker binding site in glutamate and NMDA receptor channels. Neuropharmacology 37, 139-147.
48. + channels. Science 266, 1068-1072.
49. Franqueza L., Longobardo M., Vicente J., Delpon E., Tamkun M. M., Tamargo J., Snyders D. J. and Valenzuela C. (1997) Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ. Res. 81, 1053-1064.
50. Frazier D. T., Narahashi T. and Yamada M. (1970) The site of action and active form of local anesthetics. II. Experiments with quaternary compounds. J. Pharmacol. Exp. Ther. 171, 45-51.
51. French R. J. and Dudley S. C. Jr (1999) Pore-blocking toxins as probes of voltage-dependent channels. Meth Enzymol. 294, 575-605.
52. Galper J. B. and Catterall W. A. (1979) Inhibition of sodium channels by D600. Mol. Pharmacol. 15, 174-178.
53. Garcia M. L., Gao Y., McManus O. B. and Kaczorowski G. J. (2001) Potassium channels: from scorpion venoms to high-resolution structure. Toxicon. 39, 739-748.
54. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15, 193-204.
55. Ghatpande A. S. and Sikdar S. K. (1997) Competition for binding between veratridine and KIFMK: an open channel blocking peptide of the RIIA sodium channel. J. Membr. Biol. 160, 177-182.
56. Goldmann S. and Stoltefuss J. (1991) 1,4-Dihydropyridines: effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew. Chem. Int. Ed. Engl. 30, 1559-1578.
57. Hanner M., Green B., Gao Y. D. et al. (2001) Binding of correolide to the Kv1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis. Biochemistry 40, 11687-11697.
58. Hanson D. C., Nguyen A., Mather R. J. et al. (1999) UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation. Br. J. Pharmacol. 126, 1707-1716.
59. Heginbotham L. and MacKinnon R. (1992) The aromatic binding site for tetraethylammonium ion on potassium channels. Neuron 8, 483-491.
60. Heinemann S. H., Terlau H., Stuhmer W., Imoto K. and Numa S. (1992) Calcium channel characteristics conferred on the sodium channel by single mutations. Nature 356, 441-443.
61. 2+ channels. J. Physiol. (Lond.) 528, 237-249.
62. Hess P. and Tsien R. W. (1984) Mechanism of ion permeation through calcium channels. Nature 309, 453-456.
63. Hille B. (1967) The selective inhibition of delayed potassium currents in nerve by tetraethylammonium ion. J. General Physiol. 50, 1287-1302.
64. Hille B. (2001) Ion Channels of Excitable Membranes. Sinauer Associates Inc, Sunderland, MA, USA.
65. Hockerman G. H., Peterson B. Z., Johnson B. D. and Catterall W. A. (1997) Molecular determinants of drug binding and action on 1-type calcium channels. Annu. Rev. Pharmacol. Toxicol. 37, 361-396.
66. + channel can be trapped in the open state by an intersubunit metal bridge. Neuron 21, 617-621.
67. + channels: evidence for a trap door mechanism of activation gating. J. General Physiol. 109, 527-535.
68. Huang C. J., Favre I. and Moczydlowski E. (2000) Permeation of large tetra-alkylammonium cations through mutant and wild-type voltage-gated sodium channels as revealed by relief of block at high voltage. J. General Physiol. 115, 435-454.
69. 2+ antagonist binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem. J. 347, 829-836.
70. 2+-permeable AMPA receptor channels. Neuroreport 6, 2045-2048.
71. Ito H., Klugbauer N. and Hofmann F. (1997) Transfer of the high affinity dihydropyridine sensitivity from 1-type to non-L-type calcium channel. Mol. Pharmacol. 52, 735-740.
72. 2+-perrneable AMPA receptor channels. J. Physiol. (Lond.) 549, 439-452.
73. Jiang Y., Lee A., Chen J., Cadene M., Chait B. T. and MacKinnon R. (2002a) Crystal structure and mechanism of a calcium-gated potassium channel. Nature 417, 515-522.
74. Jiang Y., Lee A., Chen J., Cadene M., Chait B. T. and MacKinnon R. (2002b) The open pore conformation of potassium channels. Nature 417, 523-526.
75. + channel. Nature 423, 33-41.
76. + channel. Nature 423, 42-48.
77. Jones K. S., VanDongen H. M. and VanDongen A. M. (2002) The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening. J. Neurosci. 22, 2044-2053.
78. Kaczorowski G. J. and Garcia M. L. (1999) Pharmacology of voltage-gated and calcium-activated potassium channels. Curr. Opin. Chem. Biol. 3, 448-458.
79. Kamboj S. K., Swanson G. T. and Cull-Candy S. G. (1995) Intracellular spermine confers rectification on rat calcium-permeable AMPA and kainate receptors. J. Physiol. (Lond.) 486, 297-303.
80. + channels by vesnarinone. Circulation 104, 951-956.
81. Kashiwagi K., Masuko T., Nguyen C. D., Kuno T., Tanaka I., Igarashi K. and Williams K. (2002) Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. Mol. Pharmacol. 61, 533-545.
82. Kavanaugh M. P., Hurst R. S., Yakel J., Varnum M. D., Adelman J. P. and North R. A. (1992) Multiple subunits of a voltage-dependent potassium channel contribute to the binding site for tetraethylammonium. Neuron 8, 493-497.
83. Khodorov B. I. and Revenko S. V. (1979) Further analysis of the mechanisms of action of batrachotoxin on the membrane of myelinated nerve. Neuroscience 4, 1315-1330.
84. Kimura T., Kinoshita E., Yamaoka K., Yuki T., Yakehiro M. and Seyama I. (2000) On site of action of grayanotoxin in domain 4 segment 6 of rat skeletal muscle sodium channel. FEBS Lett. 465, 18-22.
85. King V. F., Garcia M. L., Himmel D., Reuben J. P., Lam Y. K., Pan J. X., Han G. Q. and Kaczorowski G. J. (1988) Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J. Biol. Chem. 263, 2238-2244.
86. Kirsch G. E., Alam M. and Hartmann H. A. (1994) Differential effects of sulfhydryl reagents on saxitoxin and tetrodotoxin block of voltage-dependent Na channels. Biophys. J. 67, 2305-2315.
87. 2+-permeable AMPA receptors in rat brain by intracellular polyamines generates double rectification. J. Physiol. (Lond.) 486, 305-312.
88. Kohda K., Wang Y. and Yuzaki M. (2000) Mutation of a glutamate receptor motif reveals its role in gating and delta2 receptor channel properties. Nat. Neurosci. 3, 315-322.
89. Kroemer R. T., Koutsilieri E., Hecht P., Liedl K. R., Riederer P. and Kornhuber J. (1998) Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site. J. Med. Chem. 41, 393-400.
90. Lazdunski M. and Renaud J. F. (1982) The action of cardiotoxins on cardiac plasma membranes. Ann. Rev. Physiol. 44, 463-473.
91. Leibowitz. M. D., Sutro J. B. and Hille B. (1986) Voltage-dependent gating of veratridine-modified Na channels. J. General Physiol. 87, 25-46.
92. Li H. L., Galue A., Meadows L. and Ragsdale D. S. (1999) A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel. Mol. Pharmacol. 55, 134-141.
93. + channel determined by construction of multimeric cDNAs. Neuron 9, 861-871.
94. Linford N. J., Cantrell A. R., Qu Y., Scheuer T. and Catterall W. A. (1998) Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel. Proc. Natl Acad. Sci. USA 95, 13947-13952.
95. + channel pore. Biochemistry 39, 8161-8170.
96. 2+ channel. Biochemistry 40, 6786-6794.
97. 2+ channel. Mol. Pharmacol. 63, 499-511.
98. + channel. Neuron 19, 175-184.
99. Lopatin A. N., Makhina E. N. and Nichols C. G. (1994) Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 372, 366-369.
100. Lopez-Barneo J., Hoshi T., Heinemann S. H. and Aldrich R. W. (1993) Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels 1, 61-71.
101. MacDonald J. F., Bartlett M. C., Mody I., Pahapill P., Reynolds J. N., Salter M. W., Schneiderman J. H. and Pennefather P. S. (1991) Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J. Physiol. (Lond.) 432, 483-508.
102. MacKinnon R. (1991) Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 350, 232-235.
103. + channels. Science 250, 276-279.
104. Madeja M., Leicher T., Friederich P., Punke M. A., Haverkamp W., Musshoff U., Breithardt G. and Speckmarm E. J. (2003) Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1. Mol. Pharmacol. 63, 547-556.
105. Magazanik L. G., Buldakova S. L., Samoilova M. V., Gmiro V. E., Mellor I. R. and Usherwood P. N. (1997) Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives. J. Physiol. (Lond.). 505, 655-663.
106. Mealing G. A., Paris J., Lou A., Edwards A., Hou S. T., MacManus J. P., Hakim A. M. and Morley P. (2001) Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block. J. Neurochem. 78, 316-324.
107. Minor D. L. Jr, Masseling S. J., Jan Y. N. and Jan L. Y. (1999) Transmembrane structure of an inwardly rectifying potassium channel. Cell 96, 879-891.
108. Mitcheson J. S., Chen J., Lin M., Culberson C. and Sanguinetti M. C. (2000b) A structural basis for drug-induced long QT syndrome. Proc. Natl Acad. Sci. USA 97, 12329-12333.
109. Mitcheson J. S., Chen J. and Sanguinetti M. C. (2000a) Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J. General Physiol. 115, 229-240.
110. H] saxitoxin and mu-conotoxins. Proc. Natl Acad. Sci. USA 83, 5321-5325.
111. + channel by the gastrointestinal prokinetic agent cisapride. Am. J. Physiol. 273, H2534-H2538.
112. 2+-block site of the NMDA receptor channel. Nature 358, 673-675.
113. Mozhayeva G. N., Naumov A. P., Negulyaev Y. A. and Nosyreva E. D. (1977) The permeability of aconitine-modified sodium channels to univalent cations in myelinated nerve. Biochim. Biophys. Acta 466, 461-473.
114. + channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers. Mol. Pharmacol. 56, 404-413.
115. Nielsen K. J., Watson M., Adams D. J. et al. (2002) Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels. J. Biol. Chem. 277, 27247-27255.
116. Nishizawa N., Shirasaki T., Nakao S., Matsuda H. and Shingu K. (2002) The inhibition of the N-methyl-D-aspartate receptor channel by local anesthetics in mouse CA1 pyramidal neurons. Anesth. Analg. 94, 325-330.
117. Noda M., Suzuki H., Numa S. and Stuhmer W. (1989) A single point mutation confers tetrodotoxin and saxitoxin insensitivity on the sodium channel II. FEBS Lett. 259, 213-216.
118. H] saxitoxin binding to skeletal muscle sodium channels by geographutoxin II, a polypeptide channel blocker. J. Biol. Chem. 261, 6149-6152.
119. Olivera B. M., Gray W. R., Zeikus R., McIntosh J. M., Varga J., Rivier J., de Santos V. and Cruz L. J. (1985) Peptide neurotoxins from fish-hunting cone snails. Science 230, 1338-1343.
120. + channels examined by scanning mutagenesis. J. General Physiol. 117, 345-360.
121. + channel. Neuron 9, 307-313.
122. + channel outer vestibule. Biophys. J. 75, 2647-2657.
123. H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics. Mol. Pharmacol. 25, 219-227.
124. + channel. Proc. Natl Acad. Sci. USA 92, 11839-11843.
125. + channels by local anesthetics. Science 265, 1724-1728.
126. Rauer H. and Grissmer S. (1999) The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel. Br. J. Pharmacol. 127, 1065-1074.
127. Rosenmund C., Stern-Bach Y. and Stevens C. F. (1998) The tetrameric structure of a glutamate receptor channel. Science 280, 1596-1599.
128. Roy M., Dumaine R. and Brown A. M. (1996) HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94, 817-823.
129. Sansom M. S., Shrivastava I. H., Bright J. N., Tate J., Capener C. E. and Biggin P. C. (2002) Potassium channels: structures, models, simulations. Biochim. Biophys. Acta 1565, 294-307.
130. Satin J., Kyle J. W., Chen M., Bell P., Cribbs L. L., Fozzard H. A. and Rogart R. B. (1992) A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science 256, 1202-1205.
131. Sato K., Ishida Y., Wakamatsu K., Kato R., Honda H., Ohizumi Y., Nakamura H., Ohya M., Lancelin J. M. and Kohda D. (1991) Active site of mu-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J. Biol. Chem. 266, 16989-16991.
132. Sato C., Ueno Y., Asai K., Takahashi K., Sato M., Engel A. and Fujiyoshi Y. (2001) The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities. Nature 409, 1047-1051.
133. Scholz A. (2002) Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br. J. Anaesth. 89, 52-61.
134. Shrivastava I. H., Capener C. E., Forrest L. R. and Sansom M. S. (2000) Structure and dynamics of K channel pore-lining helices: a comparative simulation study. Biophys. J. 78, 79-92.
135. Sobolevsky A. I., Koshelev S. G. and Khodorov B. I. (1999) Probing of NMDA channels with fast blockers. J. Neurosci. 19, 10611-10626.
136. Sobolevsky A. I. and Yelshansky M. V. (2000) The trapping block of NMDA receptor channels in acutely isolated rat hippocampal neurones. J. Physiol. (Lond.) 526, 493-506.
137. Sobolevsky A. I., Beck C. and Wollmuth L. P. (2002) Molecular rearrangements of the extracellular vestibule in NMDAR channels during gating. Neuron 33, 75-85.
138. + channel. Open-channel block by methanesulfonanilides. Circ. Res. 78, 499-503.
139. Stanfield P. (1983) Tetraethylammonium ions and the potassium permeability of excitable cells. Rev. Physiol. Biochem. Pharmacol. 97, 1-67.
140. 2+ of the inward rectifier, IRK1. J. Physiol. (Lond.) 478, 1-6.
141. Stephan M. M., Potts J. F. and Agnew W. S. (1994) The microI skeletal muscle sodium channel: mutation E403Q eliminates sensitivity to tetrodotoxin but not to mu-conotoxins GIIIA and GIIIB. J. Membr. Biol. 137, 1-8.
142. Strichartz G. R. (1973) The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J. General Physiol. 62, 37-57.
143. 2+ channels. Trends Pharmacol. Sci. 19, 108-115.
144. Sun Y., Olson R., Horning M., Armstrong N., Mayer M. and Gouaux E. (2002) Mechanism of glutamate receptor desensitization. Nature 417, 245-253.
145. Sunami A., Glaaser I. W. and Fozzard H. A. (2000) A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel. Proc. Natl Acad. Sci. USA 97, 2326-2331.
146. Sunami A., Glaaser I. W. and Fozzard H. A. (2001) Structural and gating changes of the sodium channel induced by mutation of a residue in the upper third of IVS6, creating an external access path for local anesthetics. Mol. Pharmacol. 59, 684-691.
147. Tavema F. A., Cameron B. R., Hampson D. L., Wang L. Y. and MacDonald J. F. (1994) Sensitivity of AMPA receptors to pentobarbital. Eur. J. Pharmacol. 267, R3-R5.
148. Terlau H., Heinemann S. H., Stuhmer W., Pusch M., Conti F., Imoto K. and Numa S. (1991) Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett. 293, 93-96.
149. 2+ complex. J. Med. Chem. 36, 1017-1023.
150. +. J. Physiol. (Lond.) 526 Part 2, 231-240.
151. Tikhonov D. B. and Zhorov B. S. (1998) Kinked-helices model of the nicotinic acetylcholine receptor ion channel and its complexes with blockers. Simulation by Monte Carlo minimization method. Biophys. J. 74, 242-255.
152. Tikhonov D. B., Samoilova M. V., Buldakova S. L., Gmiro V. E. and Magazanik L. G. (2000) Voltage-dependent block of native AMPA receptor channels by dicationic compounds. Br. J. Pharmacol. 129, 265-274.
153. + channel and binding of channel blockers. Biophys. J. 82, 1884-1893.
154. Tikhonov D. B., Zhorov B. S. and Magazanik L. G. (1999) Intersegment hydrogen bonds as possible structural determinants of the N/Q/R. site in glutamate receptors. Biophys. J. 77, 1914-1926.
155. Toyoshima C., Nakasako M., Nomura H. and Ogawa H. (2000) Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405, 647-655.
156. 2+ channels. Europ. J. Pharmacol. 375, 311-325.
157. Ulbricht W. (1998) Effects of veratridine on sodium currents and fluxes. Rev. Physiol. Biochem. Pharmacol. 133, 1-54.
158. Valenzuela C., Delpon E., Tamkun M. M., Tamargo J. and Snyders D. J. (1995) Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys. J. 69, 418-427.
159. Vorobjev V. S. and Sharonova I. N. (1994) Tetrahydroaminoacridine blocks and prolongs NMDA receptor-mediated responses in a voltage-dependent manner. Eur. J. Pharmacol. 253, 1-8.
160. + channels. Mol. Pharmacol. 54, 389-396.
161. + channel D2-S6 residues in batrachotoxin and local anesthetic action. Mol. Pharmacol. 59, 1100-1107.
162. Wang G. K. and Wang S. Y. (2003) Veratridine block of rat skeletal muscle Nav1.4 sodium channels in the inner vestibule. J. Physiol. (Lond.) 548, 667-675.
163. Washburn M. S. and Dingledine R. (1996) Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins. J. Pharmacol. Exp. Ther. 278, 669-678.
164. Washburn M. S., Numberger M., Zhang S. and Dingledine R. (1997) Differential dependence on GIuR2 expression of three characteristic features of AMPA receptors. J. Neurosci. 17, 9393-9406.
165. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N. and Iversen L. L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl Acad. Sci. USA 83, 7104-7108.
166. Wright W. L., Robinson T. N., 3rd D'Angelo C. P. and Wright J. M. (1991) Multiple effects of tetraethylammonium on N-methyl-D-aspartate receptor-channels in mouse brain neurons in cell culture. Pharmacol. Biochem. Behav. 39, 479-485.
167. + channel D4-S6 reduce inactivated channel block by local anesthetics. Mol. Pharmacol. 54, 733-739.
168. 2+ channel agonists. J. Biol. Chem. 275, 41504-41511.
169. 2+ channel agonists. Mol. Pharmacol. 64, 235-248.
170. Yamakura T., Sakimura K., Mishina M. and Shimoji K. (1995) The sensitivity of AMPA-selective glutamate receptor channels to pentobarbital is determined by a single amino acid residue of the alpha 2 subunit. FEBS Lett. 374, 412-414.
171. Yamamoto D. (1986) Dynamics of strychnine block of single sodium channels in bovine chromaffin cells. J. Physiol. (Lond.) 370, 395-407.
172. + channel alpha subunit. J. Biol. Chem. 276, 20-27.
173. + channel alpha subunit in voltage-dependent gating and drug block. J. Biol. Chem. 277, 35393-35401.
174. Yeh J. Z. and Narahashi T. (1977) Kinetic analysis of pancuronium interaction with sodium channels in squid axon membranes. J. General Physiol. 69, 293-323.
175. + channel. Science 251, 939-942.
176. Zamponi G. W. and French R. J. (1993) Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle. Biophys. J. 65, 2335-2347.
177. 2+, and calcium entry blockers. J. Membr. Biol. 135, 119-127.
178. 2+ ions and dihydropyridine ligand. Biophys. J. 70, 22-37.
179. 2+ channel modulation by agonists and antagonists. Arch. Biochem. Biophys. 393, 22-41.
180. + channel-Fab complex at 2.0 Å resolution. Nature. 414, 43-48.
181. Zhou M., Morais-Cabral J. H., Mann S. and MacKinnon R. (2001a) Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 411, 657-661.